Frederick Derosier

Vice President, Rare Diseases, Advanced Therapies; Therapeutic Strategy Lead for Cell/Gene Therapies at Fortrea, Inc.

Speaker

Frederick Derosier is a Vice President and Therapeutic Strategy Leader with extensive experience guiding global clinical programs across rare diseases and advanced therapies. He aligns scientific strategy, operational execution, and regulatory expectations to enable high‑quality clinical development, particularly for complex modalities such as cell therapy, gene therapy, and RNA/antisense platforms. Across pharma, biotech, and CRO leadership roles, Dr. Derosier has led first-in-human through late‑stage and registrational programs, built fit‑for‑purpose operating models for advanced therapeutics, and is known for clear, disciplined communication and pragmatic problem‑solving.